王福生，302医院，北京——HBV相关实验室及人物介绍系列

bigben446

王福生，302医院，北京——HBV相关实验室及人物介绍系列

王福生院士，302医院，北京
Wei, L. and J. Li, et al. (2016). "A nationwide survey of specialist knowledge on current standard of care (Peg-IFN/RBV) and barriers of care in chronic hepatitis C patients in China." J Gastroenterol Hepatol.
Sarin, S. K. and M. Kumar, et al. (2016). "Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update." Hepatol Int 10(1): 1-98.
Xu, X. and Q. Shang, et al. (2015). "Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients." Cell Mol Immunol 12(3): 309-16.
Li, Y. and X. Wu, et al. (2015). "[Decrease in gammadeltaV 2T cells correlates with severity of liver injury and fibrosis in patients with chronic hepatitis B]." Zhonghua Gan Zang Bing Za Zhi 23(2): 94-8.
Zhu, S. S. and Q. L. Zeng, et al. (2015). "Interferon-alpha plus ribavirin yields 98 % sustained virologic response in children aged 1-5 years with iatrogenic chronic hepatitis C." Hepatol Int 9(4): 578-85.
Feng, G. and J. Y. Zhang, et al. (2014). "Interleukin-21 mediates hepatitis B virus-associated liver cirrhosis by activating hepatic stellate cells." Hepatol Res 44(10): E198-205.
Zeng, Q. L. and B. Yang, et al. (2014). "Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR zeta chain expression on CD8(+) T cells in chronic hepatitis C patients." Mol Cells 37(1): 66-73.
Bility, M. T. and L. Cheng, et al. (2014). "Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages." PLoS Pathog 10(3): e1004032.
Zhao, J. and Z. Zhang, et al. (2014). "Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment." Hepatology 59(4): 1331-42.
Zeng, Q. L. and G. H. Feng, et al. (2014). "Risk factors for liver-related mortality in chronic hepatitis C patients: a deceased case-living control study." World J Gastroenterol 20(18): 5519-26.
Xu, R. and F. Lin, et al. (2013). "Complement 5a stimulates hepatic stellate cells in vitro, and is increased in the plasma of patients with chronic hepatitis B." Immunology 138(3): 228-34.
Zhu, S. and H. Zhang, et al. (2013). "The correlation between T helper type 17 cells and clinical characters in Chinese paediatric patients with chronic hepatitis B." Clin Exp Immunol 171(3): 307-12.
Zhang, J. Y. and X. L. Wu, et al. (2013). "Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C." Eur J Immunol 43(7): 1953-62.
Zeng, Q. L. and J. Y. Zhang, et al. (2013). "Sofosbuvir and ABT-450: terminator of hepatitis C virus?" World J Gastroenterol 19(21): 3199-206.
Feng, G. and J. Y. Zhang, et al. (2013). "HCV-specific interleukin-21+CD4+ T cells responses associated with viral control  through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients." Mol Cells 36(4): 362-7.
Zhang, Z. and J. Y. Zhang, et al. (2012). "Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection." J Gastroenterol Hepatol 27(2): 223-30.
Zhang, H. F. and L. M. Wang, et al. (2012). "[A clinical study on leucogen tablets therapy efficacy during PEG-alpha interferon and alpha-interferon in chronic hepatitis B]." Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 26(2): 111-3.
Zhang, Z. and S. Zhang, et al. (2011). "Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients." Hepatology 53(1): 73-85.
Yu, S. J. and H. Geng, et al. (2011). "[Treatment of chronic hepatitis C complicated with thyroid disease by peginterferon alfa-2a: 3 cases report]." Zhonghua Gan Zang Bing Za Zhi 19(1): 69.
Zhang, J. Y. and Z. S. Zou, et al. (2011). "Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B." PLoS One 6(3): e17484.
Zhou, L. and J. L. Fu, et al. (2010). "Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma." J Gastroenterol 45(9): 968-78.
Zhang, J. Y. and C. H. Song, et al. (2010). "Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment." PLoS One 5(11): e13869.
Zou, Z. and B. Li, et al. (2009). "Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure  associated with hepatitis B virus infection." J Clin Gastroenterol 43(2): 182-90.
Shi, M. and J. Fu, et al. (2009). "Viral suppression correlates with dendritic cell restoration in chronic hepatitis B patients with autologous cytokine-induced killer cell transfusion." Liver Int 29(3): 466-74.
Shi, M. and J. Fu, et al. (2009). "Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection." Clin Immunol 132(1): 43-54.
Zhang, Z. and B. Jin, et al. (2009). "Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients." J Hepatol 50(6): 1163-73.
Wang, F. S. and J. Y. Zhang (2009). "[Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis]." Zhonghua Gan Zang Bing Za Zhi 17(3): 164-6.
Wang, F. S. and Z. Zhang (2009). "Host immunity influences disease progression and antiviral efficacy in humans infected with hepatitis B virus." Expert Rev Gastroenterol Hepatol 3(5): 499-512.
Wang, F. S. and W. W. Chen (2008). "[Anti-viral therapy and immune responses in livers of chronic hepatitis B patients]." Zhonghua Gan Zang Bing Za Zhi 16(2): 81-3.
Zhang, Z. and J. Y. Zhang, et al. (2008). "Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B." Gastroenterology 134(7): 1938-49, 1949.e1-3.
Li, Y. G. and L. E. Chen, et al. (2008). "[Dynamic changes of B7-H1 expression on mDCs and T cells in chronic hepatitis B patients treated with PEG-IFN alpha-2a]." Zhonghua Gan Zang Bing Za Zhi 16(6): 421-4.
Zhang, Z. and Z. S. Zou, et al. (2008). "Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure." J Hepatol 49(3): 396-406.
Zhang, J. Y. and Z. Zhang, et al. (2008). "Cutting edge: programmed death-1 up-regulation is involved in the attrition of cytomegalovirus-specific CD8+ T cells in acute self-limited hepatitis B virus infection." J Immunol 181(6): 3741-4.
Chen, W. and Z. Zhang, et al. (2008). "Activated plasmacytoid dendritic cells act synergistically with hepatitis B core  antigen-pulsed monocyte-derived dendritic cells in the induction of hepatitis B virus-specific CD8 T-cell response." Clin Immunol 129(2): 295-303.
Zhang, Z. and D. Chen, et al. (2007). "Increased infiltration of intrahepatic DC subsets closely correlate with viral control and liver injury in immune active pediatric patients with chronic hepatitis B." Clin Immunol 122(2): 173-80.
Shi, M. and S. Qian, et al. (2007). "Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro." Clin Exp Immunol 147(2): 277-86.
Zhang, A. M. and H. F. Wang, et al. (2007). "[Changes of peripheral plasmacytoid dendritic cells and lymphocyte subsets in chronic hepatitis B patients treated with consensus interferon alpha]." Zhonghua Gan Zang Bing Za Zhi 15(3): 184-6.
Chen, L. and Z. Zhang, et al. (2007). "B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B." J Immunol 178(10): 6634-41.
Zhang, Z. and H. Zhang, et al. (2007). "Response to interferon-alpha treatment correlates with recovery of blood plasmacytoid dendritic cells in children with chronic hepatitis B." J Hepatol 47(6): 751-9.
Wang, F. S. (2007). "Clinical immune characterization of hepatitis B virus infection and implications  for immune intervention: Progress and challenges." Hepatol Res 37 Suppl 3: S339-46.
Li, Y. G. and L. E. Chen, et al. (2007). "[Expressions and significance of B7-H1 and programmed death-1 in lymphocytes from patients with chronic hepatitis B virus infection]." Zhonghua Gan Zang Bing Za Zhi 15(10): 738-41.
Zou, Z. S. and D. P. Xu, et al. (2007). "[Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B]." Zhonghua Yi Xue Za Zhi 87(34): 2416-9.
Xu, D. and J. Fu, et al. (2006). "Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis  B." J Immunol 177(1): 739-47.
Duan, X. Z. and H. Zhuang, et al. (2005). "Decreased numbers and impaired function of circulating dendritic cell subsets in  patients with chronic hepatitis B infection (R2)." J Gastroenterol Hepatol 20(2): 234-42.
Qian, S. and M. Shi, et al. (2005). "[Phenotype and function of myeloid dendritic cells pulsed with hepatitis B virus  antigens in patients with HBV-associated hepatocellular carcinoma]." Zhonghua Yi Xue Za Zhi 85(4): 248-52.
Wang, M. and L. X. Zhang, et al. (2005). "[Sequential analyses of circulating HBV specific T helper cell response in chronic hepatitis B patients receiving antiviral treatment]." Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 19(4): 387-90.
Xu, Z. Q. and H. F. Zhang, et al. (2004). "[Association of T cell subsets with clinical status and hepatic pathology in children with chronic hepatitis B virus infection]." Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 18(2): 142-4.
Duan, X. Z. and M. Wang, et al. (2004). "Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans." J Clin Immunol 24(6): 637-46.